The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical outcomes with alpelisib (ALP) plus fulvestrant (FUL) in patients with HR-positive (HR+)/HER2-negative (HER2-) advanced breast cancer (ABC) with PIK3CA mutations (m) in routine practice at several Russian centers.
 
Lyudmila Zhukova
No Relationships to Disclose
 
Daria Filonenko
No Relationships to Disclose
 
Katerina Grechukhina
No Relationships to Disclose
 
Margarita Stepanchencko
No Relationships to Disclose
 
Rashida Orlova
No Relationships to Disclose
 
Mark Gluzman
No Relationships to Disclose
 
Almira Vakhitova
No Relationships to Disclose
 
Alla Goryainova
No Relationships to Disclose
 
Mikhail Fedyanin
No Relationships to Disclose
 
Elena Glazkova
No Relationships to Disclose
 
Daniil Stroyakovsky
No Relationships to Disclose
 
Anastasia Danilova
No Relationships to Disclose
 
Ilya Pokataev
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Eisai; Merck; Novartis; Pfizer; Pierre Fabre; Roche; Swixx BioPharma
 
Olesia Stativko
No Relationships to Disclose
 
Irina Andreyashkina
No Relationships to Disclose
 
Ivan Trotsenko
No Relationships to Disclose
 
Igor Khatkov
No Relationships to Disclose